Complementary and alternative medicine (CAM) in Mexican patients with cancer.

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Raquel Gerson-CwilichAlberto Villalobos-Prieto

Abstract

Cancer is the second cause of death in Mexico, most cases are detected at advanced stages and the use of chemotherapy is frequent. At present, more than 300 types of complementary and/or alternative medicine (CAM) treatments are known that offer different therapeutic objectives. Many patients use this type of treatments. To determine the characteristics of the patients that use CAM, to identify the aim of these treatments, the source of information and the potential benefits obtained by the patient. A questionnaire was applied from February 20 to March 5, 2004 to non-selected patients with cancer in private consultation to determine age, sex, education level, work, use of CAM, type and number of used therapies, potential benefits and monthly cost. Two groups were formed, A for users and B for non-users of CAM. Results between groups were compared and the mentioned variables were correlated with the use of alternative medicine. Group A included 37 patients and group B included 38, with no difference regarding age, education level, work and oncological diagnosis, p > 0.05; a significant trend was found as regards the feminine sex, p = 0.07, neoplasm different from breast cancer, p = 0.08 and evident association with neoplasm adva...Continue Reading

References

Sep 10, 1994·BMJ : British Medical Journal·E J MaherI Feigel
Jan 28, 1993·The New England Journal of Medicine·D M EisenbergT L Delbanco
Feb 1, 1997·Japanese Journal of Clinical Oncology·J M LiuJ Whang-Peng
May 30, 1998·JAMA : the Journal of the American Medical Association·J A Astin
Jun 3, 1999·The New England Journal of Medicine·H J BursteinJ C Weeks
Jan 6, 2000·Journal of the National Cancer Institute·M M LeeD Eisenberg
Jul 13, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M A RichardsonS E Singletary
May 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·O PaltielV Soskolne
Feb 22, 2002·Gynecologic Oncology·Elizabeth M SwisherDavid G Mutch
May 23, 2002·Alternative Therapies in Health and Medicine·David Riley, Brian Berman
Aug 15, 2002·BMC Complementary and Alternative Medicine·Joannie ShenPaul Shekelle
Sep 27, 2002·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Taka AshikagaLee Nelson
Oct 16, 2002·Annals of Internal Medicine·Karen E AdamsAlbert R Jonsen
Dec 3, 2002·Annals of Internal Medicine·Wendy A WeigerDavid M Eisenberg
Sep 11, 2003·The Medical Journal of Australia·Edzard Ernst
Oct 29, 2003·Breast Cancer Research : BCR·Edward MillsKumanan Wilson
Feb 18, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marisa A NavoJudith A Smith
Sep 1, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·G NagelD Katenkamp
Sep 3, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Kara M Kelly
Sep 21, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Mary Ann RichardsonChristina Sanders
Feb 3, 2005·The Korean Journal of Internal Medicine·Min Jae KimSook-Hyang Jeong
Feb 17, 2005·Pediatric Blood & Cancer·Dominique MartelClaudine Laurier
Feb 25, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ichinosuke HyodoShigemitsu Takashima
Apr 9, 2005·Southern Medical Journal·Moshe FrenkelVictor Sierpina

❮ Previous
Next ❯

Citations

Aug 30, 2012·BMC Health Services Research·Yi-Hsien Lin, Po-Jung Pan
Dec 18, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Ana Camila Callado AlfanoBianca Sakamoto Ribeiro Paiva
Aug 27, 2011·Evidence-based Complementary and Alternative Medicine : ECAM·I L G FariasM R C Schetinger
Jan 2, 2016·Journal of Ethnopharmacology·Nadia J Jacobo-HerreraCarlos Pérez-Plasencia
Oct 11, 2008·Phytotherapy Research : PTR·Elizabeth A Mazzio, Karam F A Soliman
Jun 22, 2010·Phytotherapy Research : PTR·Elizabeth A Mazzio, Karam F A Soliman
Dec 15, 2010·Journal of Ethnopharmacology·Angel Josabad Alonso-CastroAlejandro Garcia-Carranca
Dec 6, 2014·TheScientificWorldJournal·Elisha SoloweyHaya Lorberboum-Galski
May 10, 2016·Complementary Therapies in Clinical Practice·Gülçin Dişsiz, Medine Yilmaz
Aug 23, 2017·Critical Care Research and Practice·Verena MartiniLampros Kousoulas
Sep 3, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·José de Jesús Manríquez-TorresJesús Martín Torres-Valencia
Sep 3, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Shamima JahanMohammad S Mubarak
Nov 10, 2021·CA: a Cancer Journal for Clinicians·Jun J MaoLuis Alejandro Salicrup

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved